Ozempic’s Active Ingredient Might Also Slow Aging — In Mice, Not You Yet

A new study published in Nature suggests semaglutide — the active ingredient behind weight-loss drugs Ozempic and Wegovy — might do more than shrink waistlines. In elderly female mice, it extended lifespan by roughly 12%, with treated mice living nearly 100 days longer than untreated ones, alongside improvements in muscle function, cognitive performance and spatial memory.

Semaglutide belongs to a class of drugs called GLP-1 receptor agonists, which mimic hormones that regulate appetite and metabolism. Researchers believe it may also influence inflammation and other pathways linked to age-related decline, prompting the question: “Could drugs originally developed to treat metabolic disease also influence the biological processes that drive ageing?”

Before anyone starts stockpiling Ozempic for their birthday: researchers are clear this was an animal study — it doesn’t prove the drug extends human lifespan, and using it purely as an anti-aging treatment isn’t something the science currently supports.

Interesting science. Not a green light to self-medicate your way to immortality.

Source: Vanguard News.